-Caveat Lector- <A HREF="http://www.ctrl.org/"> </A> -Cui Bono?- Listers: Here is a write-up on an org you might want to keep track of or at least know about...this is from the financial pages of the Net...interesting to me so many Jewish people control this one....Judith ____________________________ "HGSI" -- Stock Trading Symbol -- Business Summary Human Genome Sciences, Inc. researches and develops novel, proprietary pharmaceutical and diagnostic products based on the discovery and understanding of the medical utility of genes. Using automated, high-throughput gene sequencing technology, the Company has generated a collection of partial human gene sequences and now possesses one of the largest proprietary databases of full-length human and microbial genes. The Company has isolated and characterized several thousand full-length genes and expressed and purified more than 250 potential therapeutic proteins. The Company currently is developing two proteins, MPIF-1 and KGF-2, in phase II clinical studies, evaluating additional therapeutic protein product candidates in preclinical studies, and is developing a gene therapy treatment for vascular disease based on VEGF-2 in collaboration with Vascular Genetics, Inc. The Company increases its resources and capabilities by establishing collaborations with pharmaceutical companies. Financial Summary HGSI is engaged in research and development of novel proprietary pharmaceutical and diagnostic products based on the discovery and understanding of the medical utility of genes. For the nine months ended 9/30/99, revenues fell 13% to $23.7 million. Net loss rose from $10.6 million to $24.2 million. Revenues reflect lower license fees and milestone payments. Higher loss reflects higher research and development expenses related to the start-up of the new production facility. Officers [Insider Trade Data] FY1998 Compensation Pay Exer ------------------------------------------------------------------------------ -- William Haseltine, Ph.D., 54 Chairman, CEO $591K -- Steven Mayer, 45 Sr. VP and CFO -- -- Craig Rosen, Ph.D., 41 Exec. VP of R&D, Director 417K $119K James Davis, Ph.D., 48 Sr. VP, Gen. Counsel and Sec. 289K -- Arthur Mandell, 46 Sr. VP, Corp. Devel. 279K -- Dollar amounts are as of 31-Dec-1998 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. ------------------------------------------------------------------------------ -- More from Market Guide: Highlights -Performance - Ratio Comparisons Statistics at a Glance -- NasdaqNM:HGSI As of 28-Jan-2000 Price and Volume 52-Week Low on 23-Feb-1999 $28.75 Recent Price $191.125 52-Week High on 24-Jan-2000 $241.00 Beta 1.23 Daily Volume (3-month avg) 560.6K Daily Volume (10-day avg) 1.19M Stock Performance big chart [1d | 5d | 3mo | 1yr | 2yr | 5yr | max] 52-Week Change +472.7% 52-Week Change relative to S&P500 +438.9% Share-Related Items Market Capitalization $4.42B Shares Outstanding 23.1M Float 14.6M Dividends & Splits Annual Dividend none Last Split none Per-Share Data Book Value (mrq) $8.02 Earnings (ttm) -$1.61 Earnings (mrq) -$0.42 Sales (ttm) $1.14 Cash (mrq) $12.18 Valuation Ratios Price/Book (mrq) 23.84 Price/Earnings N/A Price/Sales (ttm) 168.03 Income Statements Sales (ttm) $26.1M EBITDA (ttm) -$37.7M Income available to common (ttm) -$36.8M Profitability Profit Margin N/A Operating Margin N/A Fiscal Year Fiscal Year Ends Dec 31 Most recent quarter 30-Sep-1999 Management Effectiveness Return on Assets (ttm) -13.19% Return on Equity (ttm) -18.51% Financial Strength Current Ratio (mrq) 18.28 Debt/Equity (mrq) 0.69 Total Cash (mrq) $288.6M Short Interest As of 8-Dec-1999 Shares Short 1.93M Percent of Float 13.2% Shares Short (Prior Month) 1.63M Short Ratio 6.34 Daily Volume 304.0K See Profile Help for a description of each item above; K = thousands; M = millions; B = billions; mrq = most-recent quarter; ttm = trailing twelve months; (as of 30-Sep-1999) Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities. ------------------------------------------------------------------------------ -- Copyright © 2000 Yahoo! All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. <A HREF="http://www.ctrl.org/">www.ctrl.org</A> DECLARATION & DISCLAIMER ========== CTRL is a discussion & informational exchange list. Proselytizing propagandic screeds are not allowed. Substance—not soap-boxing! These are sordid matters and 'conspiracy theory'—with its many half-truths, misdirections and outright frauds—is used politically by different groups with major and minor effects spread throughout the spectrum of time and thought. That being said, CTRL gives no endorsement to the validity of posts, and always suggests to readers; be wary of what you read. CTRL gives no credence to Holocaust denial and nazi's need not apply. Let us please be civil and as always, Caveat Lector. ======================================================================== Archives Available at: http://home.ease.lsoft.com/archives/CTRL.html http:[EMAIL PROTECTED]/ ======================================================================== To subscribe to Conspiracy Theory Research List[CTRL] send email: SUBSCRIBE CTRL [to:] [EMAIL PROTECTED] To UNsubscribe to Conspiracy Theory Research List[CTRL] send email: SIGNOFF CTRL [to:] [EMAIL PROTECTED] Om
